Ségalat L - Search Results

1

Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.

Giacomotto J, Pertl C, Borrel C, Walter MC, Bulst S, Johnsen B, Baillie DL, Lochmüller H, Thirion C, Ségalat L. Giacomotto J, et al. Among authors: segalat l. Hum Mol Genet. 2009 Nov 1;18(21):4089-101. doi: 10.1093/hmg/ddp358. Epub 2009 Jul 31. Hum Mol Genet. 2009. PMID: 19648295

2

Blocking of striated muscle degeneration by serotonin in C. elegans.

Carre-Pierrat M, Mariol MC, Chambonnier L, Laugraud A, Heskia F, Giacomotto J, Ségalat L. Carre-Pierrat M, et al. Among authors: segalat l. J Muscle Res Cell Motil. 2006;27(3-4):253-8. doi: 10.1007/s10974-006-9070-9. Epub 2006 Jun 22. J Muscle Res Cell Motil. 2006. PMID: 16791712

3

High-throughput screening and small animal models, where are we?

Giacomotto J, Ségalat L. Giacomotto J, et al. Among authors: segalat l. Br J Pharmacol. 2010 May;160(2):204-16. doi: 10.1111/j.1476-5381.2010.00725.x. Br J Pharmacol. 2010. PMID: 20423335 Free PMC article. Review.

4

Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.

Giacomotto J, Brouilly N, Walter L, Mariol MC, Berger J, Ségalat L, Becker TS, Currie PD, Gieseler K. Giacomotto J, et al. Among authors: segalat l. Hum Mol Genet. 2013 Nov 15;22(22):4562-78. doi: 10.1093/hmg/ddt302. Epub 2013 Jun 25. Hum Mol Genet. 2013. PMID: 23804750

5

Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.

Giacomotto J, Ségalat L, Carre-Pierrat M, Gieseler K. Giacomotto J, et al. Among authors: segalat l. Methods. 2012 Jan;56(1):103-13. doi: 10.1016/j.ymeth.2011.10.010. Epub 2011 Oct 21. Methods. 2012. PMID: 22041718

6

Characterization of the Caenorhabditis elegans G protein-coupled serotonin receptors.

Carre-Pierrat M, Baillie D, Johnsen R, Hyde R, Hart A, Granger L, Ségalat L. Carre-Pierrat M, et al. Among authors: segalat l. Invert Neurosci. 2006 Dec;6(4):189-205. doi: 10.1007/s10158-006-0033-z. Epub 2006 Nov 3. Invert Neurosci. 2006. PMID: 17082916

7

Metabotyping of Caenorhabditis elegans reveals latent phenotypes.

Blaise BJ, Giacomotto J, Elena B, Dumas ME, Toulhoat P, Ségalat L, Emsley L. Blaise BJ, et al. Among authors: segalat l. Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19808-12. doi: 10.1073/pnas.0707393104. Epub 2007 Dec 5. Proc Natl Acad Sci U S A. 2007. PMID: 18077412 Free PMC article.

8

Metabolic profiling strategy of Caenorhabditis elegans by whole-organism nuclear magnetic resonance.

Blaise BJ, Giacomotto J, Triba MN, Toulhoat P, Piotto M, Emsley L, Ségalat L, Dumas ME, Elena B. Blaise BJ, et al. Among authors: segalat l. J Proteome Res. 2009 May;8(5):2542-50. doi: 10.1021/pr900012d. J Proteome Res. 2009. PMID: 19267476

9

A genome-wide collection of Mos1 transposon insertion mutants for the C. elegans research community.

Vallin E, Gallagher J, Granger L, Martin E, Belougne J, Maurizio J, Duverger Y, Scaglione S, Borrel C, Cortier E, Abouzid K, Carre-Pierrat M, Gieseler K, Ségalat L, Kuwabara PE, Ewbank JJ. Vallin E, et al. Among authors: segalat l. PLoS One. 2012;7(2):e30482. doi: 10.1371/journal.pone.0030482. Epub 2012 Feb 8. PLoS One. 2012. PMID: 22347378 Free PMC article.

10

Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.

Gaud A, Simon JM, Witzel T, Carre-Pierrat M, Wermuth CG, Ségalat L. Gaud A, et al. Among authors: segalat l. Neuromuscul Disord. 2004 Jun;14(6):365-70. doi: 10.1016/j.nmd.2004.02.011. Neuromuscul Disord. 2004. PMID: 15145337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters